PMC:7335494 / 74205-74450 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T534","span":{"begin":89,"end":99},"obj":"Body_part"},{"id":"T535","span":{"begin":158,"end":164},"obj":"Body_part"}],"attributes":[{"id":"A534","pred":"fma_id","subj":"T534","obj":"http://purl.org/sig/ont/fma/fma82738"},{"id":"A535","pred":"fma_id","subj":"T535","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"8-week intervention: 3400–3600 mg n-3 PUFA (as salmon)/day 12 ↓ CPR, ↑ anti-inflammatory fatty acid indexNo effect TNF- α, MDA ↑ n-3 PUFAs,↑ n-3/n-6 ratio in plasma and rectal biopsies; No effect on the fecal calprotectine Grimstad et al. (2011)"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T788","span":{"begin":158,"end":164},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"8-week intervention: 3400–3600 mg n-3 PUFA (as salmon)/day 12 ↓ CPR, ↑ anti-inflammatory fatty acid indexNo effect TNF- α, MDA ↑ n-3 PUFAs,↑ n-3/n-6 ratio in plasma and rectal biopsies; No effect on the fecal calprotectine Grimstad et al. (2011)"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T944","span":{"begin":38,"end":42},"obj":"Chemical"},{"id":"T946","span":{"begin":89,"end":99},"obj":"Chemical"},{"id":"T947","span":{"begin":95,"end":99},"obj":"Chemical"},{"id":"T948","span":{"begin":123,"end":126},"obj":"Chemical"},{"id":"T949","span":{"begin":133,"end":138},"obj":"Chemical"}],"attributes":[{"id":"A944","pred":"chebi_id","subj":"T944","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"},{"id":"A945","pred":"chebi_id","subj":"T944","obj":"http://purl.obolibrary.org/obo/CHEBI_76567"},{"id":"A946","pred":"chebi_id","subj":"T946","obj":"http://purl.obolibrary.org/obo/CHEBI_35366"},{"id":"A947","pred":"chebi_id","subj":"T947","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A948","pred":"chebi_id","subj":"T948","obj":"http://purl.obolibrary.org/obo/CHEBI_566274"},{"id":"A949","pred":"chebi_id","subj":"T949","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"}],"text":"8-week intervention: 3400–3600 mg n-3 PUFA (as salmon)/day 12 ↓ CPR, ↑ anti-inflammatory fatty acid indexNo effect TNF- α, MDA ↑ n-3 PUFAs,↑ n-3/n-6 ratio in plasma and rectal biopsies; No effect on the fecal calprotectine Grimstad et al. (2011)"}

{"project":"LitCovid-sentences","denotations":[{"id":"T461","span":{"begin":0,"end":20},"obj":"Sentence"},{"id":"T462","span":{"begin":21,"end":245},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"8-week intervention: 3400–3600 mg n-3 PUFA (as salmon)/day 12 ↓ CPR, ↑ anti-inflammatory fatty acid indexNo effect TNF- α, MDA ↑ n-3 PUFAs,↑ n-3/n-6 ratio in plasma and rectal biopsies; No effect on the fecal calprotectine Grimstad et al. (2011)"}

{"project":"MyTest","denotations":[{"id":"32640331-21142420-30721006","span":{"begin":240,"end":244},"obj":"21142420"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"8-week intervention: 3400–3600 mg n-3 PUFA (as salmon)/day 12 ↓ CPR, ↑ anti-inflammatory fatty acid indexNo effect TNF- α, MDA ↑ n-3 PUFAs,↑ n-3/n-6 ratio in plasma and rectal biopsies; No effect on the fecal calprotectine Grimstad et al. (2011)"}

{"project":"2_test","denotations":[{"id":"32640331-21142420-30721006","span":{"begin":240,"end":244},"obj":"21142420"}],"text":"8-week intervention: 3400–3600 mg n-3 PUFA (as salmon)/day 12 ↓ CPR, ↑ anti-inflammatory fatty acid indexNo effect TNF- α, MDA ↑ n-3 PUFAs,↑ n-3/n-6 ratio in plasma and rectal biopsies; No effect on the fecal calprotectine Grimstad et al. (2011)"}